nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Sensory disturbance—Simvastatin—atherosclerosis	0.0216	0.0272	CcSEcCtD
Nelarabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.0126	0.5	CbGdCrCtD
Nelarabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.0126	0.5	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ABCG1—atherosclerosis	0.0125	0.417	CrCbGaD
Nelarabine—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.0123	0.0155	CcSEcCtD
Nelarabine—DGUOK—Purine metabolism—GPX1—atherosclerosis	0.012	0.0835	CbGpPWpGaD
Nelarabine—Transaminases increased—Lovastatin—atherosclerosis	0.0118	0.0148	CcSEcCtD
Nelarabine—Transaminases increased—Ezetimibe—atherosclerosis	0.0116	0.0145	CcSEcCtD
Nelarabine—Transaminases increased—Simvastatin—atherosclerosis	0.011	0.0139	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.0104	0.0131	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.0102	0.0128	CcSEcCtD
Nelarabine—Blood disorder—Rosuvastatin—atherosclerosis	0.0101	0.0127	CcSEcCtD
Nelarabine—Transaminases increased—Pravastatin—atherosclerosis	0.00997	0.0125	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00975	0.0123	CcSEcCtD
Nelarabine—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00956	0.012	CcSEcCtD
Nelarabine—Adenosine triphosphate—HSPA1B—atherosclerosis	0.00944	0.316	CrCbGaD
Nelarabine—Burning sensation—Niacin—atherosclerosis	0.00886	0.0111	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00881	0.0111	CcSEcCtD
Nelarabine—Rhabdomyolysis—Lovastatin—atherosclerosis	0.0081	0.0102	CcSEcCtD
Nelarabine—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00795	0.00999	CcSEcCtD
Nelarabine—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00758	0.00953	CcSEcCtD
Nelarabine—Hypertonia—Rosuvastatin—atherosclerosis	0.00742	0.00932	CcSEcCtD
Nelarabine—Sensory loss—Pravastatin—atherosclerosis	0.007	0.0088	CcSEcCtD
Nelarabine—Rhabdomyolysis—Niacin—atherosclerosis	0.00696	0.00875	CcSEcCtD
Nelarabine—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00685	0.00861	CcSEcCtD
Nelarabine—Hyperbilirubinaemia—Niacin—atherosclerosis	0.00677	0.00851	CcSEcCtD
Nelarabine—Hyperuricaemia—Niacin—atherosclerosis	0.00664	0.00835	CcSEcCtD
Nelarabine—Amnesia—Rosuvastatin—atherosclerosis	0.00654	0.00822	CcSEcCtD
Nelarabine—Blood uric acid increased—Niacin—atherosclerosis	0.00627	0.00788	CcSEcCtD
Nelarabine—DGUOK—Nucleotide metabolism—GPX1—atherosclerosis	0.00603	0.0419	CbGpPWpGaD
Nelarabine—Neuropathy—Pravastatin—atherosclerosis	0.00569	0.00716	CcSEcCtD
Nelarabine—Amnesia—Lovastatin—atherosclerosis	0.00554	0.00696	CcSEcCtD
Nelarabine—Amnesia—Ezetimibe—atherosclerosis	0.00543	0.00683	CcSEcCtD
Nelarabine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00542	0.00681	CcSEcCtD
Nelarabine—Hypertonia—Niacin—atherosclerosis	0.0054	0.00679	CcSEcCtD
Nelarabine—Pain in extremity—Lovastatin—atherosclerosis	0.0052	0.00654	CcSEcCtD
Nelarabine—Amnesia—Simvastatin—atherosclerosis	0.00518	0.00651	CcSEcCtD
Nelarabine—Pain in extremity—Ezetimibe—atherosclerosis	0.00511	0.00642	CcSEcCtD
Nelarabine—Depression—Rosuvastatin—atherosclerosis	0.00472	0.00593	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CSF1R—atherosclerosis	0.00469	0.0326	CbGpPWpGaD
Nelarabine—Amnesia—Pravastatin—atherosclerosis	0.00468	0.00589	CcSEcCtD
Nelarabine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00464	0.00583	CcSEcCtD
Nelarabine—Adenosine triphosphate—ABCA1—atherosclerosis	0.00461	0.154	CrCbGaD
Nelarabine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.0046	0.00578	CcSEcCtD
Nelarabine—Muscular weakness—Ezetimibe—atherosclerosis	0.0045	0.00566	CcSEcCtD
Nelarabine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00448	0.00563	CcSEcCtD
Nelarabine—Sinusitis—Rosuvastatin—atherosclerosis	0.00444	0.00558	CcSEcCtD
Nelarabine—Muscular weakness—Simvastatin—atherosclerosis	0.00429	0.0054	CcSEcCtD
Nelarabine—ADA—Purine metabolism—GPX1—atherosclerosis	0.00398	0.0277	CbGpPWpGaD
Nelarabine—Muscular weakness—Niacin—atherosclerosis	0.00394	0.00496	CcSEcCtD
Nelarabine—Infestation NOS—Ezetimibe—atherosclerosis	0.00393	0.00495	CcSEcCtD
Nelarabine—Infestation—Ezetimibe—atherosclerosis	0.00393	0.00495	CcSEcCtD
Nelarabine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00393	0.00494	CcSEcCtD
Nelarabine—Abdominal distension—Niacin—atherosclerosis	0.00389	0.00489	CcSEcCtD
Nelarabine—Muscular weakness—Pravastatin—atherosclerosis	0.00388	0.00488	CcSEcCtD
Nelarabine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00386	0.00485	CcSEcCtD
Nelarabine—Abdominal distension—Pravastatin—atherosclerosis	0.00383	0.00481	CcSEcCtD
Nelarabine—Sinusitis—Lovastatin—atherosclerosis	0.00376	0.00473	CcSEcCtD
Nelarabine—Depression—Simvastatin—atherosclerosis	0.00374	0.0047	CcSEcCtD
Nelarabine—Mental disorder—Rosuvastatin—atherosclerosis	0.00372	0.00468	CcSEcCtD
Nelarabine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00372	0.00468	CcSEcCtD
Nelarabine—Sinusitis—Ezetimibe—atherosclerosis	0.00369	0.00464	CcSEcCtD
Nelarabine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00368	0.00462	CcSEcCtD
Nelarabine—DCK—Purine metabolism—GPX1—atherosclerosis	0.00368	0.0256	CbGpPWpGaD
Nelarabine—Sinusitis—Simvastatin—atherosclerosis	0.00352	0.00442	CcSEcCtD
Nelarabine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00348	0.00437	CcSEcCtD
Nelarabine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00347	0.00436	CcSEcCtD
Nelarabine—Adenosine triphosphate—AKT1—atherosclerosis	0.00338	0.113	CrCbGaD
Nelarabine—Depression—Pravastatin—atherosclerosis	0.00338	0.00425	CcSEcCtD
Nelarabine—Stomatitis—Niacin—atherosclerosis	0.00336	0.00422	CcSEcCtD
Nelarabine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00332	0.00418	CcSEcCtD
Nelarabine—Chills—Lovastatin—atherosclerosis	0.00323	0.00406	CcSEcCtD
Nelarabine—Cough—Rosuvastatin—atherosclerosis	0.00323	0.00406	CcSEcCtD
Nelarabine—Angiopathy—Ezetimibe—atherosclerosis	0.0032	0.00403	CcSEcCtD
Nelarabine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00318	0.004	CcSEcCtD
Nelarabine—Sinusitis—Pravastatin—atherosclerosis	0.00318	0.004	CcSEcCtD
Nelarabine—Arthralgia—Rosuvastatin—atherosclerosis	0.00315	0.00396	CcSEcCtD
Nelarabine—Myalgia—Rosuvastatin—atherosclerosis	0.00315	0.00396	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—MPO—atherosclerosis	0.00315	0.0219	CbGpPWpGaD
Nelarabine—Mental disorder—Ezetimibe—atherosclerosis	0.00309	0.00389	CcSEcCtD
Nelarabine—Hypoaesthesia—Niacin—atherosclerosis	0.00308	0.00387	CcSEcCtD
Nelarabine—Malnutrition—Ezetimibe—atherosclerosis	0.00307	0.00386	CcSEcCtD
Nelarabine—Dysgeusia—Lovastatin—atherosclerosis	0.00307	0.00386	CcSEcCtD
Nelarabine—Oedema peripheral—Niacin—atherosclerosis	0.00305	0.00383	CcSEcCtD
Nelarabine—Confusional state—Rosuvastatin—atherosclerosis	0.00304	0.00383	CcSEcCtD
Nelarabine—Back pain—Lovastatin—atherosclerosis	0.00303	0.00381	CcSEcCtD
Nelarabine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00303	0.00381	CcSEcCtD
Nelarabine—Chills—Simvastatin—atherosclerosis	0.00302	0.0038	CcSEcCtD
Nelarabine—Infection—Rosuvastatin—atherosclerosis	0.003	0.00377	CcSEcCtD
Nelarabine—Back pain—Ezetimibe—atherosclerosis	0.00297	0.00374	CcSEcCtD
Nelarabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00296	0.00372	CcSEcCtD
Nelarabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00296	0.00372	CcSEcCtD
Nelarabine—Vision blurred—Lovastatin—atherosclerosis	0.00295	0.00371	CcSEcCtD
Nelarabine—Mental disorder—Simvastatin—atherosclerosis	0.00295	0.00371	CcSEcCtD
Nelarabine—Tremor—Lovastatin—atherosclerosis	0.00294	0.00369	CcSEcCtD
Nelarabine—Eye disorder—Niacin—atherosclerosis	0.00289	0.00363	CcSEcCtD
Nelarabine—Dysgeusia—Simvastatin—atherosclerosis	0.00287	0.00361	CcSEcCtD
Nelarabine—Anaemia—Ezetimibe—atherosclerosis	0.00284	0.00357	CcSEcCtD
Nelarabine—Cardiac disorder—Pravastatin—atherosclerosis	0.00283	0.00355	CcSEcCtD
Nelarabine—Angiopathy—Niacin—atherosclerosis	0.00281	0.00353	CcSEcCtD
Nelarabine—Leukopenia—Lovastatin—atherosclerosis	0.00281	0.00353	CcSEcCtD
Nelarabine—Chills—Niacin—atherosclerosis	0.00277	0.00349	CcSEcCtD
Nelarabine—Vision blurred—Simvastatin—atherosclerosis	0.00276	0.00347	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00275	0.00346	CcSEcCtD
Nelarabine—Tremor—Simvastatin—atherosclerosis	0.00275	0.00345	CcSEcCtD
Nelarabine—Chills—Pravastatin—atherosclerosis	0.00273	0.00343	CcSEcCtD
Nelarabine—Insomnia—Rosuvastatin—atherosclerosis	0.00273	0.00343	CcSEcCtD
Nelarabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00271	0.00341	CcSEcCtD
Nelarabine—Anaemia—Simvastatin—atherosclerosis	0.00271	0.00341	CcSEcCtD
Nelarabine—Malnutrition—Niacin—atherosclerosis	0.00269	0.00338	CcSEcCtD
Nelarabine—Cough—Ezetimibe—atherosclerosis	0.00268	0.00337	CcSEcCtD
Nelarabine—Myalgia—Lovastatin—atherosclerosis	0.00267	0.00335	CcSEcCtD
Nelarabine—Arthralgia—Lovastatin—atherosclerosis	0.00267	0.00335	CcSEcCtD
Nelarabine—Chest pain—Lovastatin—atherosclerosis	0.00267	0.00335	CcSEcCtD
Nelarabine—Leukopenia—Simvastatin—atherosclerosis	0.00262	0.0033	CcSEcCtD
Nelarabine—Arthralgia—Ezetimibe—atherosclerosis	0.00262	0.00329	CcSEcCtD
Nelarabine—Chest pain—Ezetimibe—atherosclerosis	0.00262	0.00329	CcSEcCtD
Nelarabine—Myalgia—Ezetimibe—atherosclerosis	0.00262	0.00329	CcSEcCtD
Nelarabine—Dysgeusia—Pravastatin—atherosclerosis	0.0026	0.00326	CcSEcCtD
Nelarabine—Constipation—Rosuvastatin—atherosclerosis	0.00258	0.00324	CcSEcCtD
Nelarabine—Pain—Rosuvastatin—atherosclerosis	0.00258	0.00324	CcSEcCtD
Nelarabine—Confusional state—Lovastatin—atherosclerosis	0.00258	0.00324	CcSEcCtD
Nelarabine—Infection—Lovastatin—atherosclerosis	0.00254	0.00319	CcSEcCtD
Nelarabine—Vision blurred—Niacin—atherosclerosis	0.00254	0.00319	CcSEcCtD
Nelarabine—Confusional state—Ezetimibe—atherosclerosis	0.00253	0.00318	CcSEcCtD
Nelarabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.0025	0.00315	CcSEcCtD
Nelarabine—Vision blurred—Pravastatin—atherosclerosis	0.0025	0.00314	CcSEcCtD
Nelarabine—Myalgia—Simvastatin—atherosclerosis	0.0025	0.00314	CcSEcCtD
Nelarabine—Chest pain—Simvastatin—atherosclerosis	0.0025	0.00314	CcSEcCtD
Nelarabine—Arthralgia—Simvastatin—atherosclerosis	0.0025	0.00314	CcSEcCtD
Nelarabine—Infection—Ezetimibe—atherosclerosis	0.00249	0.00313	CcSEcCtD
Nelarabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00249	0.00313	CcSEcCtD
Nelarabine—Tremor—Pravastatin—atherosclerosis	0.00248	0.00312	CcSEcCtD
Nelarabine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00247	0.0031	CcSEcCtD
Nelarabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00246	0.00309	CcSEcCtD
Nelarabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00246	0.00309	CcSEcCtD
Nelarabine—Anaemia—Pravastatin—atherosclerosis	0.00245	0.00308	CcSEcCtD
Nelarabine—Anorexia—Lovastatin—atherosclerosis	0.00244	0.00307	CcSEcCtD
Nelarabine—Confusional state—Simvastatin—atherosclerosis	0.00241	0.00303	CcSEcCtD
Nelarabine—Leukopenia—Niacin—atherosclerosis	0.00241	0.00303	CcSEcCtD
Nelarabine—Oedema—Simvastatin—atherosclerosis	0.00239	0.00301	CcSEcCtD
Nelarabine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00239	0.003	CcSEcCtD
Nelarabine—Infection—Simvastatin—atherosclerosis	0.00238	0.00299	CcSEcCtD
Nelarabine—Leukopenia—Pravastatin—atherosclerosis	0.00237	0.00298	CcSEcCtD
Nelarabine—DGUOK—Metabolism—LDLRAP1—atherosclerosis	0.00237	0.0165	CbGpPWpGaD
Nelarabine—Loss of consciousness—Niacin—atherosclerosis	0.00237	0.00297	CcSEcCtD
Nelarabine—Cough—Niacin—atherosclerosis	0.00235	0.00295	CcSEcCtD
Nelarabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00234	0.00295	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00233	0.00293	CcSEcCtD
Nelarabine—Insomnia—Lovastatin—atherosclerosis	0.00231	0.00291	CcSEcCtD
Nelarabine—Cough—Pravastatin—atherosclerosis	0.00231	0.00291	CcSEcCtD
Nelarabine—Paraesthesia—Lovastatin—atherosclerosis	0.0023	0.00289	CcSEcCtD
Nelarabine—Arthralgia—Niacin—atherosclerosis	0.00229	0.00288	CcSEcCtD
Nelarabine—Myalgia—Niacin—atherosclerosis	0.00229	0.00288	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00229	0.00287	CcSEcCtD
Nelarabine—Anorexia—Simvastatin—atherosclerosis	0.00228	0.00287	CcSEcCtD
Nelarabine—Dyspnoea—Lovastatin—atherosclerosis	0.00228	0.00287	CcSEcCtD
Nelarabine—Insomnia—Ezetimibe—atherosclerosis	0.00227	0.00285	CcSEcCtD
Nelarabine—Chest pain—Pravastatin—atherosclerosis	0.00226	0.00284	CcSEcCtD
Nelarabine—Arthralgia—Pravastatin—atherosclerosis	0.00226	0.00284	CcSEcCtD
Nelarabine—Myalgia—Pravastatin—atherosclerosis	0.00226	0.00284	CcSEcCtD
Nelarabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00225	0.00283	CcSEcCtD
Nelarabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00224	0.00281	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PLTP—atherosclerosis	0.00223	0.0155	CbGpPWpGaD
Nelarabine—Decreased appetite—Lovastatin—atherosclerosis	0.00222	0.0028	CcSEcCtD
Nelarabine—Fatigue—Lovastatin—atherosclerosis	0.00221	0.00277	CcSEcCtD
Nelarabine—Oedema—Niacin—atherosclerosis	0.0022	0.00276	CcSEcCtD
Nelarabine—Constipation—Lovastatin—atherosclerosis	0.00219	0.00275	CcSEcCtD
Nelarabine—Pain—Lovastatin—atherosclerosis	0.00219	0.00275	CcSEcCtD
Nelarabine—Confusional state—Pravastatin—atherosclerosis	0.00218	0.00274	CcSEcCtD
Nelarabine—Decreased appetite—Ezetimibe—atherosclerosis	0.00218	0.00274	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00218	0.00274	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00217	0.00272	CcSEcCtD
Nelarabine—Asthenia—Rosuvastatin—atherosclerosis	0.00217	0.00272	CcSEcCtD
Nelarabine—Insomnia—Simvastatin—atherosclerosis	0.00216	0.00272	CcSEcCtD
Nelarabine—Oedema—Pravastatin—atherosclerosis	0.00216	0.00272	CcSEcCtD
Nelarabine—Fatigue—Ezetimibe—atherosclerosis	0.00216	0.00272	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—SIRT1—atherosclerosis	0.00216	0.015	CbGpPWpGaD
Nelarabine—Infection—Pravastatin—atherosclerosis	0.00215	0.0027	CcSEcCtD
Nelarabine—Paraesthesia—Simvastatin—atherosclerosis	0.00215	0.0027	CcSEcCtD
Nelarabine—Pain—Ezetimibe—atherosclerosis	0.00215	0.0027	CcSEcCtD
Nelarabine—Constipation—Ezetimibe—atherosclerosis	0.00215	0.0027	CcSEcCtD
Nelarabine—Dyspnoea—Simvastatin—atherosclerosis	0.00213	0.00268	CcSEcCtD
Nelarabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00212	0.00266	CcSEcCtD
Nelarabine—Feeling abnormal—Lovastatin—atherosclerosis	0.00211	0.00265	CcSEcCtD
Nelarabine—Anorexia—Niacin—atherosclerosis	0.00209	0.00263	CcSEcCtD
Nelarabine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00209	0.00263	CcSEcCtD
Nelarabine—Decreased appetite—Simvastatin—atherosclerosis	0.00208	0.00261	CcSEcCtD
Nelarabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00207	0.0026	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00207	0.0026	CcSEcCtD
Nelarabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00207	0.0026	CcSEcCtD
Nelarabine—Fatigue—Simvastatin—atherosclerosis	0.00206	0.00259	CcSEcCtD
Nelarabine—Anorexia—Pravastatin—atherosclerosis	0.00206	0.00259	CcSEcCtD
Nelarabine—Hypotension—Niacin—atherosclerosis	0.00205	0.00258	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00205	0.00258	CcSEcCtD
Nelarabine—Constipation—Simvastatin—atherosclerosis	0.00205	0.00257	CcSEcCtD
Nelarabine—Pain—Simvastatin—atherosclerosis	0.00205	0.00257	CcSEcCtD
Nelarabine—Abdominal pain—Lovastatin—atherosclerosis	0.00202	0.00254	CcSEcCtD
Nelarabine—Body temperature increased—Lovastatin—atherosclerosis	0.00202	0.00254	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.002	0.00252	CcSEcCtD
Nelarabine—ADA—Nucleotide metabolism—GPX1—atherosclerosis	0.002	0.0139	CbGpPWpGaD
Nelarabine—Dizziness—Rosuvastatin—atherosclerosis	0.002	0.00251	CcSEcCtD
Nelarabine—Insomnia—Niacin—atherosclerosis	0.00199	0.0025	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—UTS2—atherosclerosis	0.00198	0.0138	CbGpPWpGaD
Nelarabine—Abdominal pain—Ezetimibe—atherosclerosis	0.00198	0.00249	CcSEcCtD
Nelarabine—Body temperature increased—Ezetimibe—atherosclerosis	0.00198	0.00249	CcSEcCtD
Nelarabine—Paraesthesia—Niacin—atherosclerosis	0.00197	0.00248	CcSEcCtD
Nelarabine—Feeling abnormal—Simvastatin—atherosclerosis	0.00197	0.00248	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00197	0.00248	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—GSTM1—atherosclerosis	0.00197	0.0137	CbGpPWpGaD
Nelarabine—Dyspnoea—Niacin—atherosclerosis	0.00196	0.00246	CcSEcCtD
Nelarabine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00196	0.00246	CcSEcCtD
Nelarabine—Insomnia—Pravastatin—atherosclerosis	0.00196	0.00246	CcSEcCtD
Nelarabine—Somnolence—Niacin—atherosclerosis	0.00195	0.00246	CcSEcCtD
Nelarabine—Paraesthesia—Pravastatin—atherosclerosis	0.00194	0.00244	CcSEcCtD
Nelarabine—DGUOK—Metabolism—LTA4H—atherosclerosis	0.00193	0.0134	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCG8—atherosclerosis	0.00193	0.0134	CbGpPWpGaD
Nelarabine—Dyspnoea—Pravastatin—atherosclerosis	0.00193	0.00242	CcSEcCtD
Nelarabine—Decreased appetite—Niacin—atherosclerosis	0.00191	0.0024	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.0019	0.00238	CcSEcCtD
Nelarabine—Abdominal pain—Simvastatin—atherosclerosis	0.00189	0.00238	CcSEcCtD
Nelarabine—Body temperature increased—Simvastatin—atherosclerosis	0.00189	0.00238	CcSEcCtD
Nelarabine—Headache—Rosuvastatin—atherosclerosis	0.00189	0.00238	CcSEcCtD
Nelarabine—Decreased appetite—Pravastatin—atherosclerosis	0.00188	0.00236	CcSEcCtD
Nelarabine—Pain—Niacin—atherosclerosis	0.00188	0.00236	CcSEcCtD
Nelarabine—Fatigue—Pravastatin—atherosclerosis	0.00187	0.00234	CcSEcCtD
Nelarabine—Constipation—Pravastatin—atherosclerosis	0.00185	0.00233	CcSEcCtD
Nelarabine—Pain—Pravastatin—atherosclerosis	0.00185	0.00233	CcSEcCtD
Nelarabine—DCK—Nucleotide metabolism—GPX1—atherosclerosis	0.00185	0.0128	CbGpPWpGaD
Nelarabine—Asthenia—Lovastatin—atherosclerosis	0.00184	0.00231	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—AHR—atherosclerosis	0.00182	0.0126	CbGpPWpGaD
Nelarabine—Asthenia—Ezetimibe—atherosclerosis	0.0018	0.00226	CcSEcCtD
Nelarabine—Gastrointestinal pain—Niacin—atherosclerosis	0.0018	0.00226	CcSEcCtD
Nelarabine—Nausea—Rosuvastatin—atherosclerosis	0.00179	0.00225	CcSEcCtD
Nelarabine—Feeling abnormal—Pravastatin—atherosclerosis	0.00178	0.00224	CcSEcCtD
Nelarabine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00177	0.00222	CcSEcCtD
Nelarabine—Diarrhoea—Lovastatin—atherosclerosis	0.00175	0.0022	CcSEcCtD
Nelarabine—Body temperature increased—Niacin—atherosclerosis	0.00174	0.00218	CcSEcCtD
Nelarabine—Abdominal pain—Niacin—atherosclerosis	0.00174	0.00218	CcSEcCtD
Nelarabine—Asthenia—Simvastatin—atherosclerosis	0.00172	0.00216	CcSEcCtD
Nelarabine—Diarrhoea—Ezetimibe—atherosclerosis	0.00172	0.00216	CcSEcCtD
Nelarabine—Abdominal pain—Pravastatin—atherosclerosis	0.00171	0.00215	CcSEcCtD
Nelarabine—Body temperature increased—Pravastatin—atherosclerosis	0.00171	0.00215	CcSEcCtD
Nelarabine—Dizziness—Lovastatin—atherosclerosis	0.00169	0.00213	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—CST3—atherosclerosis	0.00168	0.0117	CbGpPWpGaD
Nelarabine—Dizziness—Ezetimibe—atherosclerosis	0.00166	0.00209	CcSEcCtD
Nelarabine—Diarrhoea—Simvastatin—atherosclerosis	0.00164	0.00206	CcSEcCtD
Nelarabine—Vomiting—Lovastatin—atherosclerosis	0.00163	0.00204	CcSEcCtD
Nelarabine—Headache—Lovastatin—atherosclerosis	0.0016	0.00201	CcSEcCtD
Nelarabine—Vomiting—Ezetimibe—atherosclerosis	0.0016	0.00201	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NAMPT—atherosclerosis	0.00159	0.011	CbGpPWpGaD
Nelarabine—Dizziness—Simvastatin—atherosclerosis	0.00158	0.00199	CcSEcCtD
Nelarabine—Asthenia—Niacin—atherosclerosis	0.00158	0.00198	CcSEcCtD
Nelarabine—Headache—Ezetimibe—atherosclerosis	0.00157	0.00198	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—SIRT1—atherosclerosis	0.00155	0.0108	CbGpPWpGaD
Nelarabine—Asthenia—Pravastatin—atherosclerosis	0.00155	0.00195	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ABCG1—atherosclerosis	0.00153	0.0106	CbGpPWpGaD
Nelarabine—Vomiting—Simvastatin—atherosclerosis	0.00152	0.00191	CcSEcCtD
Nelarabine—Nausea—Lovastatin—atherosclerosis	0.00152	0.00191	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—F7—atherosclerosis	0.0015	0.0105	CbGpPWpGaD
Nelarabine—Diarrhoea—Niacin—atherosclerosis	0.0015	0.00189	CcSEcCtD
Nelarabine—Headache—Simvastatin—atherosclerosis	0.0015	0.00188	CcSEcCtD
Nelarabine—Nausea—Ezetimibe—atherosclerosis	0.00149	0.00187	CcSEcCtD
Nelarabine—Diarrhoea—Pravastatin—atherosclerosis	0.00148	0.00186	CcSEcCtD
Nelarabine—Dizziness—Niacin—atherosclerosis	0.00145	0.00183	CcSEcCtD
Nelarabine—DGUOK—Metabolism—LCAT—atherosclerosis	0.00144	0.00999	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FABP4—atherosclerosis	0.00144	0.00999	CbGpPWpGaD
Nelarabine—Dizziness—Pravastatin—atherosclerosis	0.00143	0.0018	CcSEcCtD
Nelarabine—Nausea—Simvastatin—atherosclerosis	0.00142	0.00179	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOA4—atherosclerosis	0.00141	0.00981	CbGpPWpGaD
Nelarabine—Vomiting—Niacin—atherosclerosis	0.0014	0.00176	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP7A1—atherosclerosis	0.00139	0.00964	CbGpPWpGaD
Nelarabine—Headache—Niacin—atherosclerosis	0.00138	0.00173	CcSEcCtD
Nelarabine—Vomiting—Pravastatin—atherosclerosis	0.00138	0.00173	CcSEcCtD
Nelarabine—Headache—Pravastatin—atherosclerosis	0.00136	0.0017	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—GHRL—atherosclerosis	0.00134	0.00932	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—SERPINE1—atherosclerosis	0.00134	0.00929	CbGpPWpGaD
Nelarabine—Nausea—Niacin—atherosclerosis	0.00131	0.00164	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—ADIPOQ—atherosclerosis	0.0013	0.00903	CbGpPWpGaD
Nelarabine—Nausea—Pravastatin—atherosclerosis	0.00128	0.00162	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP27A1—atherosclerosis	0.00128	0.00891	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALOX5AP—atherosclerosis	0.00121	0.00844	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALOX15—atherosclerosis	0.00121	0.00844	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLA2G2A—atherosclerosis	0.00121	0.00844	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOA2—atherosclerosis	0.00121	0.00844	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCG5—atherosclerosis	0.0012	0.00834	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00118	0.0082	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LPA—atherosclerosis	0.00116	0.00805	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BGN—atherosclerosis	0.00112	0.0078	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—atherosclerosis	0.00111	0.00772	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOA5—atherosclerosis	0.00111	0.00772	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLA2G1B—atherosclerosis	0.00107	0.00743	CbGpPWpGaD
Nelarabine—DGUOK—adipose tissue—atherosclerosis	0.00104	0.186	CbGeAlD
Nelarabine—DGUOK—Metabolism—ALOX5—atherosclerosis	0.00103	0.00718	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—SIRT1—atherosclerosis	0.00102	0.00711	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000961	0.00668	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PRKCG—atherosclerosis	0.000935	0.00651	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NAMPT—atherosclerosis	0.000926	0.00644	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LIPC—atherosclerosis	0.00092	0.0064	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOC3—atherosclerosis	0.000914	0.00636	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LDLR—atherosclerosis	0.000909	0.00632	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000893	0.00621	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CETP—atherosclerosis	0.000888	0.00617	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SCARB1—atherosclerosis	0.00085	0.00591	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARA—atherosclerosis	0.00085	0.00591	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—LEP—atherosclerosis	0.000806	0.00561	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HMGCR—atherosclerosis	0.000803	0.00558	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LDLRAP1—atherosclerosis	0.000787	0.00548	CbGpPWpGaD
Nelarabine—ADA—connective tissue—atherosclerosis	0.000772	0.139	CbGeAlD
Nelarabine—ADA—Circadian rythm related genes—NOS2—atherosclerosis	0.000751	0.00523	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLTP—atherosclerosis	0.00074	0.00515	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LDLRAP1—atherosclerosis	0.000726	0.00505	CbGpPWpGaD
Nelarabine—DGUOK—liver—atherosclerosis	0.000726	0.131	CbGeAlD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000719	0.005	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCA1—atherosclerosis	0.000715	0.00498	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARG—atherosclerosis	0.000702	0.00489	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLTP—atherosclerosis	0.000683	0.00475	CbGpPWpGaD
Nelarabine—ADA—cardiovascular system—atherosclerosis	0.000672	0.121	CbGeAlD
Nelarabine—ADA—Metabolism—LTA4H—atherosclerosis	0.000642	0.00446	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG8—atherosclerosis	0.000642	0.00446	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000641	0.00446	CbGpPWpGaD
Nelarabine—POLA1—adipose tissue—atherosclerosis	0.000639	0.115	CbGeAlD
Nelarabine—ADA—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000633	0.0044	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HMOX1—atherosclerosis	0.000614	0.00427	CbGpPWpGaD
Nelarabine—ADA—adipose tissue—atherosclerosis	0.000592	0.107	CbGeAlD
Nelarabine—DCK—Metabolism—LTA4H—atherosclerosis	0.000592	0.00412	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG8—atherosclerosis	0.000592	0.00412	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOB—atherosclerosis	0.000588	0.00409	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—atherosclerosis	0.000572	0.00398	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LPL—atherosclerosis	0.000561	0.0039	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GPX1—atherosclerosis	0.000548	0.00381	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000542	0.00377	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CD36—atherosclerosis	0.000533	0.00371	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG1—atherosclerosis	0.000507	0.00353	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MTHFR—atherosclerosis	0.000505	0.00352	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARA—atherosclerosis	0.000496	0.00345	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AGT—atherosclerosis	0.00048	0.00334	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FABP4—atherosclerosis	0.000477	0.00332	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LCAT—atherosclerosis	0.000477	0.00332	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MAPK8—atherosclerosis	0.000471	0.00328	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOE—atherosclerosis	0.000471	0.00327	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000469	0.00326	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG1—atherosclerosis	0.000468	0.00326	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA4—atherosclerosis	0.000468	0.00326	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAV1—atherosclerosis	0.000466	0.00324	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOA1—atherosclerosis	0.000465	0.00324	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP7A1—atherosclerosis	0.00046	0.0032	CbGpPWpGaD
Nelarabine—POLA1—liver—atherosclerosis	0.000448	0.0806	CbGeAlD
Nelarabine—DCK—Metabolism—LCAT—atherosclerosis	0.00044	0.00306	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FABP4—atherosclerosis	0.00044	0.00306	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA4—atherosclerosis	0.000432	0.003	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP27A1—atherosclerosis	0.000425	0.00296	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CG—atherosclerosis	0.000425	0.00295	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP7A1—atherosclerosis	0.000424	0.00295	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—atherosclerosis	0.00041	0.00285	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALOX15—atherosclerosis	0.000403	0.0028	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALOX5AP—atherosclerosis	0.000403	0.0028	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLA2G2A—atherosclerosis	0.000403	0.0028	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA2—atherosclerosis	0.000403	0.0028	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—INS—atherosclerosis	0.000402	0.0028	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG5—atherosclerosis	0.000398	0.00277	CbGpPWpGaD
Nelarabine—DCK—adipose tissue—atherosclerosis	0.000394	0.0709	CbGeAlD
Nelarabine—DCK—Metabolism—CYP27A1—atherosclerosis	0.000392	0.00273	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000389	0.0027	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPA—atherosclerosis	0.000384	0.00267	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BGN—atherosclerosis	0.000372	0.00259	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALOX5AP—atherosclerosis	0.000372	0.00259	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALOX15—atherosclerosis	0.000372	0.00259	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA2—atherosclerosis	0.000372	0.00259	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLA2G2A—atherosclerosis	0.000372	0.00259	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—atherosclerosis	0.000369	0.00256	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA5—atherosclerosis	0.000369	0.00256	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG5—atherosclerosis	0.000367	0.00255	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLA2G1B—atherosclerosis	0.000355	0.00247	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPA—atherosclerosis	0.000355	0.00247	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NOS3—atherosclerosis	0.000353	0.00245	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BGN—atherosclerosis	0.000344	0.00239	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALOX5—atherosclerosis	0.000343	0.00238	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA5—atherosclerosis	0.00034	0.00237	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000337	0.00235	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000332	0.00231	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLA2G1B—atherosclerosis	0.000327	0.00228	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—atherosclerosis	0.000322	0.00224	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALOX5—atherosclerosis	0.000316	0.0022	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NAMPT—atherosclerosis	0.000307	0.00214	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000306	0.00213	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LIPC—atherosclerosis	0.000305	0.00212	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOC3—atherosclerosis	0.000304	0.00211	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LDLR—atherosclerosis	0.000302	0.0021	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—atherosclerosis	0.000301	0.00209	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CETP—atherosclerosis	0.000295	0.00205	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.00029	0.00202	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NAMPT—atherosclerosis	0.000284	0.00197	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SCARB1—atherosclerosis	0.000282	0.00196	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LIPC—atherosclerosis	0.000282	0.00196	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000281	0.00196	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOC3—atherosclerosis	0.00028	0.00195	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LDLR—atherosclerosis	0.000278	0.00194	CbGpPWpGaD
Nelarabine—DCK—liver—atherosclerosis	0.000276	0.0497	CbGeAlD
Nelarabine—DCK—Metabolism—CETP—atherosclerosis	0.000272	0.00189	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMGCR—atherosclerosis	0.000266	0.00185	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000262	0.00183	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SCARB1—atherosclerosis	0.00026	0.00181	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMGCR—atherosclerosis	0.000246	0.00171	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCA1—atherosclerosis	0.000237	0.00165	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCA1—atherosclerosis	0.000219	0.00152	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—atherosclerosis	0.000204	0.00142	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000195	0.00136	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOB—atherosclerosis	0.000195	0.00136	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—atherosclerosis	0.00019	0.00132	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMOX1—atherosclerosis	0.000188	0.00131	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	0.000188	0.0013	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPL—atherosclerosis	0.000186	0.0013	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—atherosclerosis	0.000182	0.00126	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOB—atherosclerosis	0.00018	0.00125	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CD36—atherosclerosis	0.000177	0.00123	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—atherosclerosis	0.000175	0.00122	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPL—atherosclerosis	0.000172	0.0012	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—atherosclerosis	0.000168	0.00117	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—atherosclerosis	0.000168	0.00117	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARA—atherosclerosis	0.000165	0.00114	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CD36—atherosclerosis	0.000163	0.00114	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—atherosclerosis	0.000162	0.00113	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AGT—atherosclerosis	0.000159	0.00111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—atherosclerosis	0.000156	0.00109	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—atherosclerosis	0.000155	0.00108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—atherosclerosis	0.000155	0.00108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA1—atherosclerosis	0.000154	0.00107	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARA—atherosclerosis	0.000152	0.00106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AGT—atherosclerosis	0.000147	0.00102	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—atherosclerosis	0.000144	0.001	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—atherosclerosis	0.000143	0.000993	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA1—atherosclerosis	0.000143	0.000991	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—atherosclerosis	0.000141	0.000981	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	0.00014	0.000975	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—atherosclerosis	0.000136	0.000946	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INS—atherosclerosis	0.000133	0.000928	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—atherosclerosis	0.00013	0.000905	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—atherosclerosis	0.000126	0.000873	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—atherosclerosis	0.000125	0.000872	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INS—atherosclerosis	0.000123	0.000857	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—atherosclerosis	0.000122	0.000851	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—atherosclerosis	0.000117	0.000814	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—atherosclerosis	0.000113	0.000785	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—atherosclerosis	0.000108	0.000751	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—atherosclerosis	0.000107	0.000744	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—atherosclerosis	9.88e-05	0.000687	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—atherosclerosis	5.38e-05	0.000374	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—atherosclerosis	4.96e-05	0.000345	CbGpPWpGaD
